MiMedx Group, Inc.MDXGNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank49
3Y CAGR-27.0%
5Y CAGR-10.3%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-27.0%/yr
vs -30.2%/yr prior
5Y CAGR
-10.3%/yr
Recent deceleration
Acceleration
+3.2pp
Accelerating
Percentile
P49
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.84% |
| Q3 2025 | 15.33% |
| Q2 2025 | 11.79% |
| Q1 2025 | -5.06% |
| Q4 2024 | 10.53% |
| Q3 2024 | -3.61% |
| Q2 2024 | 2.95% |
| Q1 2024 | -2.44% |
| Q4 2023 | 6.27% |
| Q3 2023 | 0.56% |
| Q2 2023 | 13.37% |
| Q1 2023 | -3.63% |
| Q4 2022 | 9.88% |
| Q3 2022 | 1.21% |
| Q2 2022 | 13.57% |
| Q1 2022 | -12.63% |
| Q4 2021 | 6.87% |
| Q3 2021 | -7.47% |
| Q2 2021 | 13.67% |
| Q1 2021 | -12.52% |
| Q4 2020 | 6.60% |
| Q3 2020 | 19.86% |
| Q2 2020 | -13.10% |
| Q1 2020 | -19.19% |
| Q4 2019 | -14.02% |
| Q3 2019 | 31.77% |
| Q2 2019 | 1.33% |
| Q1 2019 | -28.12% |
| Q4 2018 | 6.47% |
| Q3 2018 | -8.86% |
| Q2 2018 | 13.39% |
| Q1 2018 | -3.88% |
| Q4 2017 | 3.52% |
| Q3 2017 | 10.68% |
| Q2 2017 | 5.24% |
| Q1 2017 | 3.91% |
| Q4 2016 | 8.45% |
| Q3 2016 | 12.36% |
| Q2 2016 | 7.45% |
| Q1 2016 | 2.96% |